BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25576670)

  • 1. The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure.
    Makadia S; Simmons T; Augustine S; Kovell L; Harris C; Chibungu A; Parakh K
    Am J Med; 2015 May; 128(5):527-31. PubMed ID: 25576670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G; Fraeman K; Teerlink JR; Mullahy J; Salon J; Sterz R; Durtschi A; Padley RJ
    Eur J Health Econ; 2010 Apr; 11(2):185-93. PubMed ID: 19582491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
    J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary outpatient congestive heart failure clinic: impact on hospital admissions and emergency room visits.
    Martineau P; Frenette M; Blais L; Sauvé C
    Can J Cardiol; 2004 Oct; 20(12):1205-11. PubMed ID: 15494772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
    J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
    Vaishnav J; Hubbard A; Chasler JE; Lepley D; Cuomo K; Riley S; Menzel K; Fajardo J; Sharma K; Judge DP; Russell SD; Gilotra NA
    Am Heart J; 2021 Mar; 233():122-131. PubMed ID: 33352187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short call admission on length of stay and quality of care for acute decompensated heart failure.
    Schuberth JL; Elasy TA; Butler J; Greevy R; Speroff T; Dittus RS; Roumie CL
    Circulation; 2008 May; 117(20):2637-44. PubMed ID: 18427131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.
    Barsuk JH; Gordon RA; Cohen ER; Cotts WG; Malkenson D; Yancy CW; Williams MV
    Congest Heart Fail; 2013; 19(2):53-60. PubMed ID: 23336425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM).
    Wong YW; Fonarow GC; Mi X; Peacock WF; Mills RM; Curtis LH; Qualls LG; Hernandez AF
    Am Heart J; 2013 Aug; 166(2):349-56. PubMed ID: 23895819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II).
    Eur Heart J; 2001 Jun; 22(12):1021-31. PubMed ID: 11428837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial.
    Stewart S; Carrington MJ; Marwick TH; Davidson PM; Macdonald P; Horowitz JD; Krum H; Newton PJ; Reid C; Chan YK; Scuffham PA
    J Am Coll Cardiol; 2012 Oct; 60(14):1239-48. PubMed ID: 23017533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.
    Pacho C; Domingo M; Núñez R; Lupón J; Moliner P; de Antonio M; González B; Santesmases J; Vela E; Tor J; Bayes-Genis A
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):631-638. PubMed ID: 28215922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.